ML22249A127

Shine Technologies, LLC Final Safety Analysis Report, Chapter 10, Rev. 0, Experimental Facilities

ML22249A127
Person / Time
Site:	SHINE Medical Technologies
Issue date:	08/31/2022
From:	SHINE Technologies, SHINE Health. Illuminated
To:	Office of Nuclear Reactor Regulation
Shared Package
ML22249A148	List: ML22249A125 ML22249A126 ML22249A127 ML22249A128 ML22249A129 ML22249A130 ML22249A131 ML22249A132 ML22249A133 ML22249A134 ML22249A135 ML22249A136 ML22249A137 ML22249A138 ML22249A139 ML22249A140 ML22249A141 ML22249A142 ML22249A143 ML22249A144 ML22249A145 ML22249A146
References
2022-SMT-0077
Download: ML22249A127 (6)

Text

EXPERIMENTAL FACILITIES TABLE OF CONTENTS tion Title Page 1

SUMMARY

DESCRIPTION ............................................................................... 10.1-1 2 REFERENCES ................................................................................................... 10.2-1 NE Medical Technologies 10-i Rev. 0

mber Title e

NE Medical Technologies 10-ii Rev. 0

mber Title e

NE Medical Technologies 10-iii Rev. 0

onym/Abbreviation Definition e

NE Medical Technologies 10-iv Rev. 0

1

SUMMARY

DESCRIPTION SHINE facility does not contain experimental facilities as described in NUREG-1537, Part 1, delines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors:

mat and Content (USNRC, 1996) and the Interim Staff Guidance Augmenting NUREG-1537, t 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power ctors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous mogeneous Reactors (USNRC, 2012).

NE Medical Technologies 10.1-1 Rev. 0

NRC, 1996. Guidelines for Preparing and Reviewing Applications for the Licensing of

-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory mmission, February 1996.

NRC, 2012. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for paring and Reviewing Applications for the Licensing of Non-Power Reactors: Format and tent, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous ctors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory mmission, October 17, 2012.

NE Medical Technologies 10.2-1 Rev. 0